Immutep (IMMP) Interest & Investment Income (2015 - 2017)
Immutep's (IMMP) quarterly Interest & Investment Income came in at $14608.8 in Q2 2017, down 57.54% YoY from $34404.3 in Q2 2016, and down 9.08% on a QoQ basis from $16067.7 in Q1 2017.
Immutep (IMMP) Interest & Investment Income (2015 - 2017) Analysis & Trends
Immutep (IMMP) has 3 years of Interest & Investment Income data on file, last reported at $14608.8 in Q2 2017.
- Quarterly Interest & Investment Income fell 57.54% year-over-year to $14608.8 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $112874.1 (changed N/A YoY) and the FY2025 annual result came in at $3.4 million, up 32.33% from the prior year.
- Interest & Investment Income declined to $14608.8 in Q2 2017, from $16067.7 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $155.5 million in Q2 2015 to a low of $14608.8 in Q2 2017.
- A 3-year average of $25.9 million and a median of $36460.2 in 2016 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2016 — Interest & Investment Income plunged 99.98% — and 2017, when it sank 57.54%.
- Tracing IMMP's Interest & Investment Income over 3 years: stood at $155.5 million in 2015, then plunged by 99.97% to $47793.3 in 2016, then tumbled by 69.43% to $14608.8 in 2017.
- The last three Interest & Investment Income figures came in at $14608.8 (Q2 2017), $16067.7 (Q1 2017), and $47793.3 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Immutep | 56.46 Mn | -8.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 14,608.79 |
| Mar 31, 2017 | 16,067.67 |
| Dec 31, 2016 | 47,793.34 |
| Jun 30, 2016 | 34,404.31 |
| Mar 31, 2016 | 38,516.06 |
| Jun 30, 2015 | 155.48 Mn |